Navidea Biopharmaceuticals - 52 Year Dividend History | NAVB
Historical dividend payout and yield for Navidea Biopharmaceuticals (NAVB) since 1971. The current TTM dividend payout for Navidea Biopharmaceuticals (NAVB) as of October 05, 2023 is $0.00. The current dividend yield for Navidea Biopharmaceuticals as of October 05, 2023 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$0.004B |
$0.000B |
|
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek(R), AZD4694 and RIGScan(TM). Navidea Biopharmaceuticals, Inc., formerly Neoprobe Corporation, is headquartered in Dublin, Ohio.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
